2seventy bio, Inc. (TSVT)
NASDAQ: TSVT · Real-Time Price · USD
2.610
-0.070 (-2.61%)
Feb 21, 2025, 4:00 PM EST - Market closed
2seventy bio Employees
2seventy bio had 274 employees as of December 31, 2023. The number of employees decreased by 151 or -35.53% compared to the previous year.
Employees
274
Change (1Y)
-151
Growth (1Y)
-35.53%
Revenue / Employee
$166,496
Profits / Employee
-$345,069
Market Cap
134.65M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 274 | -151 | -35.53% |
| Dec 31, 2022 | 425 | -12 | -2.75% |
| Dec 31, 2021 | 437 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 72,000 |
TSVT News
- 16 days ago - 2seventy bio Reports Preliminary* Full-Year U.S. Abecma Sales and Select Financial Results - Business Wire
- 5 weeks ago - Top 5 Cancer Pharma Stocks With Strong Risk/Reward In 2025 - Seeking Alpha
- 3 months ago - 2seventy bio, Inc. (TSVT) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - 2seventy bio Reports Third Quarter Financial Results and Recent Operational Progress - Business Wire
- 3 months ago - 2seventy bio to Report Third Quarter 2024 Financial Results and Participate in Upcoming Investor Conference - Business Wire
- 4 months ago - Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against 2seventy bio, Inc. (TSVT) And Encourages Shareholders to Reach Out - Accesswire
- 4 months ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against 2seventy bio, Inc. (TSVT) and Encourages Shareholders to Learn More About the Investigation - Accesswire
- 4 months ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating 2seventy bio, Inc. (TSVT) And Encourages Investors to Connect - Accesswire